Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
Authors:
- 1 November 2020
- journal article
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 9 (6) , 602-606
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening ModelJournal of the American Society of Cytopathology, 2016
- Increased Cervical Cancer Risk Associated With Screening at Longer IntervalsObstetrics & Gynecology, 2015
- Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre‐invasive phaseInternational Journal of Cancer, 2014
- 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer PrecursorsObstetrics & Gynecology, 2013
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI: Journal of the National Cancer Institute, 2013
- The HPV test has similar sensitivity but more overdiagnosis than the Pap test—A randomised health services study on cervical cancer screening in FinlandInternational Journal of Cancer, 2012
- Screening and cervical cancer cure: population based cohort studyBMJ, 2012
- Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in ItalyCancer Epidemiology, Biomarkers & Prevention, 2010
- Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3Australian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and CancerObstetrics & Gynecology, 2010